EcoR1 Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

EcoR1 Capital’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-379,945	Closed	-$1.79M	–	78
2020 Q3	$1.79M	Hold	379,945	–	–	0.13%	40
2020 Q2	$2.32M	Buy	379,945 +123,870	+48%	+$510K	0.17%	41
2020 Q1	$581K	Buy	+256,075	New	+$1.09M	0.06%	49
2019 Q1	–	Sell	-326,775	Closed	-$3.04M	–	57
2018 Q4	$3.04M	Buy	+326,775	New	+$3.89M	0.3%	43
2018 Q2	–	Sell	-1,240,470	Closed	-$21.3M	–	46
2018 Q1	$21.3M	Buy	+1,240,470	New	+$24.2M	2.14%	13
2017 Q1	–	Sell	-298,712	Closed	-$15M	–	41
2016 Q4	$15M	Buy	298,712 +12,100	+4%	+$636K	4.77%	9
2016 Q3	$15M	Buy	+286,612	New	+$13.7M	4.62%	8
2016 Q2	–	Sell	-500,757	Closed	-$20.3M	–	39
2016 Q1	$20.3M	Sell	500,757 -218,243	-30%	-$7.5M	7.11%	2
2015 Q4	$29.8M	Buy	719,000 +570,000	+383%	+$19.1M	9.37%	2
2015 Q3	$2.29M	Buy	+149,000	New	+$3.2M	1.04%	18

Other funds holding FPRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EcoR1 Capital's FPRX Position: Q4 2020 in Review

EcoR1 Capital sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2020, closing a stake of 379,945 shares — an estimated $1.79M sold.

EcoR1 Capital first reported a position in FPRX in Q3 2015 and held it in 10 quarters. The position peaked at $29.8M in Q4 2015. 125 funds tracked by Wall St. Rank hold FPRX as of Q4 2020.

EcoR1 Capital reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
EcoR1 Capital sold 379,945 Five Prime Therapeutics, Inc. shares in Q4 2020, an estimated $1.79M.
EcoR1 Capital first reported a position in Five Prime Therapeutics, Inc. in Q3 2015 and held it in 10 quarters.
EcoR1 Capital's Five Prime Therapeutics, Inc. position peaked at $29.8M in Q4 2015.
125 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2020.

Based on EcoR1 Capital's 13F filing for Q4 2020, filed 16 Feb 2021.